Editorial: the never-ending story-Helicobacter pylori and peptic ulcer disease. Authors' reply
- PMID: 34699095
- DOI: 10.1111/apt.16654
Editorial: the never-ending story-Helicobacter pylori and peptic ulcer disease. Authors' reply
Comment on
-
Long-term risk of upper gastrointestinal bleeding after Helicobacter pylori eradication: a population-based cohort study.Aliment Pharmacol Ther. 2021 Nov;54(9):1162-1169. doi: 10.1111/apt.16604. Epub 2021 Sep 16. Aliment Pharmacol Ther. 2021. PMID: 34528716
-
Editorial: the never-ending story-Helicobacter pylori and peptic ulcer disease.Aliment Pharmacol Ther. 2021 Nov;54(10):1350-1351. doi: 10.1111/apt.16617. Aliment Pharmacol Ther. 2021. PMID: 34699099 No abstract available.
References
REFERENCES
-
- Sugano K, Howden CW. Editorial: the never ending story - Helicobacter pylori and peptic ulcer disease. Aliment Pharmacol Ther. 2021;54:1350-1351.
-
- Jiang F, Guo C-G, Cheung KS, Leung WK. Long-term risk of upper gastrointestinal bleeding after Helicobacter pylori eradication: a population-based cohort study. Aliment Pharmacol Ther. 2021;54:1162-1169.
-
- Gu Q, Xia HH, Wang JD, et al. Update on clarithromycin resistance in Helicobacter pylori in Hong Kong and its effect on clarithromycin-based triple therapy. Digestion. 2006;73:101-106.
-
- Kuo Y-T, Liou J-M, El-Omar EM, et al. Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2017;2:707-715.
-
- Hunt RH, Bazzoli F. Review article: should NSAID/low-dose aspirin takers be tested routinely for H pylori infection and treated if positive? Implications for primary risk of ulcer and ulcer relapse after initial healing. Aliment Pharmacol Ther. 2004;19(Suppl 1):9-16.
Publication types
MeSH terms
LinkOut - more resources
Medical